Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin - Wikidata - wikimedia - TriplyDB

Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin

Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin

http://www.wikidata.org/entity/Q28386284

about

Splice isoforms as therapeutic targets for colorectal cancer From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels Targeting survivin in cancer: novel drug development approaches.MicroRNA regulation and therapeutic targeting of survivin in cancer.Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia.YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity.A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib Ilf3 and NF90 functions in RNA biology.Harnessing Solute Carrier Transporters for Precision Oncology.YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.Targeting survivin as a potential new treatment for chondrosarcoma of bone.Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.YM155 exerts potent cytotoxic activity against quiescent (G0/G1) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1.Discovery and cellular stress pathway analysis of 1,4-naphthoquinone derivatives with novel, highly potent broad-spectrum anticancer activity.YM155 enhances docetaxel efficacy in ovarian cancer.Acremopeptin, a new peptaibol from Acremonium sp. PF1450.Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.

P2860

Q27006500-F1DF5BEC-0CE3-4E2B-BFB2-00BC8C614056 Q28393309-522F89FA-6414-4713-8CBE-4C3B2BCB582B Q28397941-765EF0CB-0922-46D1-948C-47E970548829 Q33634679-DE92CA6A-889A-4918-840C-DE5BF736A5EA Q33764288-B0C43ED8-DB0C-41B8-9CBF-87895A190322 Q34954296-10FC9246-58DA-46C4-963E-6700DD153445 Q34991312-2B6C31D6-2212-4934-BD9B-E10325693045 Q35049080-05C238B3-E7F0-4C1D-B1D5-54AD23D69DA9 Q35205627-1C88FE48-BBF4-4582-91C1-5606D9B41A93 Q35914683-F0165A87-3AE6-4B43-B437-5BC0D04C25E6 Q36210899-0CD1B087-67D0-48EB-B48F-9286147F994B Q37021087-AAF6040E-11F0-4C2A-8CD9-F683FC1DA6D8 Q37200511-B3106360-BEA5-49BA-BBF0-878E9983994A Q37520240-D39E4BB1-5BCC-4441-9FB6-B7BB13E2928C Q38261272-92715810-825B-4A16-85CF-E99D7D9BE24E Q39204754-2393321B-BB80-44A5-9D6C-E0BEC70DA7C1 Q41281151-1F066755-C86E-4E11-B844-06B9E571A244 Q41621110-E6DA5AC1-D70F-4092-A92D-AF2F05C32CE9 Q42419178-C8283B77-13FC-4355-A834-B67F9CD99DA7 Q45058251-2CC0287A-DA70-4504-8D72-CF2C40F5E79A Q49238703-62F4D479-8476-422C-8859-96BA30787EAF Q50109248-A4D59224-6148-48FC-A62F-13995AD0DD51 Q52595117-A8227823-FED7-4055-B33D-C17BF162F309 Q53506276-66977E5D-6CEA-43D2-8B4E-3AF516D11648 Q53755710-B81E723F-73BF-4412-A46B-6EB015BD4395

P2860

Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin

http://www.wikidata.org/entity/Q28386284

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@ast

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@en

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@nl

type

label

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@ast

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@en

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@nl

prefLabel

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@ast

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@en

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@nl

P1433

Q28386284-3AEBA9C1-79C8-4BC6-918E-20BE0D5B4E77

P1476

Q28386284-BFA1DBF8-4F88-4AF1-80C7-E22435ED9FCC

P2093

Q28386284-15202774-032B-41FF-B0C1-AB10BCDEBC95

Q28386284-17606152-6294-436E-8A0F-50E0D8517429

Q28386284-186A7A78-173F-4741-AC39-608301A29FAF

Q28386284-1FC31700-62CA-48FF-9D62-3164B32C9E2A

Q28386284-2AEE4BE2-6E3E-44E6-B4E3-B6FCF18D0E17

Q28386284-44A0E1D0-67CD-4FF5-B6D5-5E647C361698

Q28386284-48466E62-5B51-41D6-9D61-E56AE97255FE

Q28386284-4BE0123D-BBDE-447C-BA72-73BD67848EAF

Q28386284-4FE10A7E-156F-42B8-971D-6A5425CAFDB3

Q28386284-4FF6807B-13D3-468B-B489-D2619A6DEB96

P2860

Q28386284-0215969B-FAFE-4D1C-8EC1-6451861D20D6

Q28386284-0F8894AC-DE66-42BD-8567-0ADC3BB29EB7

Q28386284-1231DE68-D27B-4FA7-9BEC-0E7897C7859B

Q28386284-1AC4BE7D-8432-4D5B-8F7E-84BB0336AA23

Q28386284-1C56B89D-DC75-43F6-A4B1-9ED8442CC864

Q28386284-1E648C5D-0132-4764-84D7-256783AF7FEE

Q28386284-24525D56-8D2B-464A-A509-7F20DA91C8AB

Q28386284-24A41E6C-2CF8-43D2-8973-E217105125C9

Q28386284-27C580CB-C636-428B-A3BB-248FCF853995

Q28386284-30E1F98F-5144-4E30-B4F2-1CA524BB4D82

P304

Q28386284-5189CACC-5BB5-47D7-A208-4818C179607B

P31

Q28386284-83E5E3B9-DA05-451A-B4ED-AAB309BF25F2

P3181

Q28386284-04C6F692-F045-4207-BB72-B84C1D5CBE2A

P356

Q28386284-9AA5D579-D9F8-4C29-98DE-6D162C56E9AB

P407

Q28386284-0D879BCD-7702-47ED-82A5-94751DF69545

P433

Q28386284-2FF316B3-84DF-4337-9061-C2AA1F8C5A53

P478

Q28386284-862FC3C2-574A-4FC6-B953-1711DE886A9A

P577

Q28386284-10BAA237-BDAE-4F2E-8644-2C9194265A39

P5875

Q28386284-F15AA7A2-FF37-4C07-AECA-F171540434A4

P698

Q28386284-9C8A4D28-052B-4C9D-B6BD-07A684B52A4A

P921

Q28386284-6b3ffbe0-63d9-479e-a8db-ca9e07b245c3

P932

Q28386284-7CDF636E-5441-40C8-8A50-7F68D8085CDB

P3181

P356

MCP.M111.013243

P1433

Molecular & Cellular Proteomics

P1476

Interleukin enhancer-binding f ...... 155, a suppressant of survivin

@en

P2093

Akira Matsuhisa

http://www.w3.org/2001/XMLSchema#string

Aya Kita

http://www.w3.org/2001/XMLSchema#string

Hiroshi Koutoku

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yokota

http://www.w3.org/2001/XMLSchema#string

Isao Kinoyama

http://www.w3.org/2001/XMLSchema#string

Kentaro Yamanaka

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Furuichi

http://www.w3.org/2001/XMLSchema#string

Masahiro Takeuchi

http://www.w3.org/2001/XMLSchema#string

Masanori Naito

http://www.w3.org/2001/XMLSchema#string

Masao Sasamata

http://www.w3.org/2001/XMLSchema#string

P2860

Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3

Confirmation of gene expression-based prediction of survival in non-small cell lung cancer

Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

The RNA binding protein nuclear factor 90 functions as both a positive and negative regulator of gene expression in mammalian cells

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

P304

M111.013243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2671803

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/MCP.M111.013243

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221971024

http://www.w3.org/2001/XMLSchema#string

P698

22442257

http://www.w3.org/2001/XMLSchema#string

P921

P932

3394938

http://www.w3.org/2001/XMLSchema#string